92 related articles for article (PubMed ID: 34530692)
21. Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes.
Norman M; Navér L; Söderling J; Ahlberg M; Hervius Askling H; Aronsson B; Byström E; Jonsson J; Sengpiel V; Ludvigsson JF; Håkansson S; Stephansson O
JAMA; 2021 May; 325(20):2076-2086. PubMed ID: 33914014
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
23. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
[TBL] [Abstract][Full Text] [Related]
24. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study.
Ullgren H; Camuto A; Rosas S; Pahnke S; Ginman B; Enblad G; Glimelius I; Fransson P; Friesland S; Liu LL
Acta Oncol; 2021 Nov; 60(11):1459-1465. PubMed ID: 34334081
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
27. Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2.
Ginman B; Pahnke S; Freyhult E; Hoffman T; Kolstad L; Rönnberg B; Lundkvist Å; Hamberg Levedahl K; Enblad G; Glimelius I
Acta Oncol; 2023 Dec; 62(12):1707-1715. PubMed ID: 37729083
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
29. CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19.
McRae AD; Hohl CM; Rosychuk R; Vatanpour S; Ghaderi G; Archambault PM; Brooks SC; Cheng I; Davis P; Hayward J; Lang E; Ohle R; Rowe B; Welsford M; Yadav K; Morrison LJ; Perry J;
BMJ Open; 2021 Dec; 11(12):e055832. PubMed ID: 34857584
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
[TBL] [Abstract][Full Text] [Related]
31. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
[TBL] [Abstract][Full Text] [Related]
32. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
Madhusoodhan PP; Pierro J; Musante J; Kothari P; Gampel B; Appel B; Levy A; Tal A; Hogan L; Sharma A; Feinberg S; Kahn A; Pinchinat A; Bhatla T; Glasser CL; Satwani P; Raetz EA; Onel K; Carroll WL
Pediatr Blood Cancer; 2021 Mar; 68(3):e28843. PubMed ID: 33338306
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of hospital-acquired SARS-CoV-2 infection in the Canadian first wave epicentre: a retrospective cohort study.
Melançon E; Brosseau M; Bartoli A; Labbé AC; Lavallée C; Marchand-Senécal X; Wang HT
CMAJ Open; 2022; 10(1):E74-E81. PubMed ID: 35105684
[TBL] [Abstract][Full Text] [Related]
34. Incidence and case fatality rate of COVID-19 in patients with active epilepsy.
Cabezudo-García P; Ciano-Petersen NL; Mena-Vázquez N; Pons-Pons G; Castro-Sánchez MV; Serrano-Castro PJ
Neurology; 2020 Sep; 95(10):e1417-e1425. PubMed ID: 32554773
[TBL] [Abstract][Full Text] [Related]
35. Case Fatality Rate of COVID-19 and its Relationship to Sociodemographic Characteristics in Ecuador, 2020.
Flores Sacoto KM; Sanchez Del Hierro GA; Moreno-Piedrahita Hernández FG; Jarrin Estupiñan JX
Int J Public Health; 2022; 67():1604768. PubMed ID: 36147885
[No Abstract] [Full Text] [Related]
36. COVID-19-related mortality in cancer patients in an Irish setting.
Linehan A; Fitzpatrick O; Cowzer D; Hennessy MA; Coyne ZL; Nolan A; Clarke M; Dhonaill RN; Hennessy BT; Morris PG; Grogan L; Breathnach O
Ir J Med Sci; 2022 Oct; 191(5):2013-2018. PubMed ID: 34697787
[TBL] [Abstract][Full Text] [Related]
37. Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center.
Fernandes GA; Feriani D; França E Silva ILA; Mendonça E Silva DR; Arantes PE; Canteras JDS; da Silva RR; Curado MP
Semin Oncol; 2021 Apr; 48(2):171-180. PubMed ID: 33573780
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 Disease in Syrian Patients With Cancer: Clinical Manifestations, Laboratory Findings, Treatment, and Outcomes.
Najjar M; Albuaini S; Fadel M; Aljbawi A; Mohsen F; Sulaiman S; Koudsi A
JCO Glob Oncol; 2022 Mar; 8():e2100283. PubMed ID: 35230875
[TBL] [Abstract][Full Text] [Related]
39. [Limitations of life-sustaining treatment in hospitalized patients with COVID-19: A retrospective study in a Swedish healthcare region].
Öhrling G; Taxbro K
Lakartidningen; 2022 Nov; 119():. PubMed ID: 36448934
[TBL] [Abstract][Full Text] [Related]
40. The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations.
Abdihamid O; Cai C; Kapesa L; Zeng S
Cancer Manag Res; 2020; 12():8923-8933. PubMed ID: 33061588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
